Search - tctmd.com

Displaying 481 - 500 of 684

Sort: Relevancy | Date

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

Presentation TCT 2017

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Sanjay Kaul

October 30, 2017

Presentation TCT 2017

Trial In the Pocket: Myheartcounts

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Alan C. Yeung

October 30, 2017

Presentation TCT 2017

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

Presenter: Gregg W. Stone, Shao-Liang Chen

October 30, 2017

Presentation TCT 2017

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Presenter: Gregg W. Stone, Suzanne J. Baron

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Presenter: Gregg W. Stone, Holger Thiele

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

September 15, 2017

Presentation SOLACI 2017

Clinical Evidence of TAVR in Intermediate Risk Patients: Lessons from Clinical Trials

Presenter: Andreas Baumbach

August 02, 2017

Presentation TVT 2017

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

Clinical Trials in Transcatheter Mitral Valve Repair Techniques: Update and Critical Appraisal

Presenter: Francesco Maisano, Gregg W. Stone

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Advertisement

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Trial In the Pocket: Myheartcounts

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Making the EHR Useful For Research: ADAPTABLE

Keeping It Simple: Large Pragmatic Trials

DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

The Inflammatory Hypothesis After CANTOS: CIRT

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Should Alleviating ISCHEMIA Be the Goal?

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

Clinical Evidence of TAVR in Intermediate Risk Patients: Lessons from Clinical Trials

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Clinical Trials in Transcatheter Mitral Valve Repair Techniques: Update and Critical Appraisal

Device Design Features and Findings From EU Clinical Trials

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content